Hosted on MSN1d
CHOP doctors named 'Disruptors of the Year' for groundbreaking sickle cell gene therapy
The Philadelphia Citizen is recognizing CHOP doctors Alexis Thompson and Dr. Stephan Grupp with the 'Disruptors of the Year' ...
Sickle cell gene therapies are gaining steam
Nearly a year after new sickle cell gene therapies were approved, CNBC's Bertha Coombs reports a small number of patients are ...
14-Year-Old Boy Discovers He Needs a Heart Transplant During a Family Vacation After Experiencing This Symptom (Exclusive)
On a family vacation, 14-year-old Jaden Hartley discovered he needed a heart transplant after experiencing this symptom. Now ...
Harvard Medical School2d
Creating the World’s First CRISPR Medicine, for Sickle Cell Disease
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
Dying to serve: Dozens of recruits have died nationwide while training to become police officers
At least 29 recruits have died during basic training at law enforcement academies nationwide in the last decade.
Medscape10d
Sickle Cell Trait Widely Misinterpreted As Cause of Death
A new review and policy statement underscore the inaccuracy of sickle cell trait as a cause of death on autopsies.
WCJB2d
Just Like You: Young girl, mother write children’s book to help others understand Sickle Cell Anemia
Simmie White is taking control of her own story. The six-year-old girl and her mother want others to understand more about ...
emjreviews.com1d
Sickle Cell Trait Not Linked to Exertion-Related Death, Study Finds
A SYSTEMATIC review by the American Society of Hematology (ASH) has found no evidence to support sickle cell trait (SCT) as a cause of acute pain crises or sudden exertion-related death. This finding ...
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
Robin Roberts marks 12 years since 'GMA' return after stem cell transplant
"Good Morning America" co-anchor Robin Roberts is marking 12 years since she returned to the anchor desk after receiving a ...
FiercePharma1d
Once valued at $10B, bluebird bio sold to private equity firms for $29M
There is a catch. If the private equity firms can boost sales of bluebird’s three gene therapies to $600 million—over any ...
Bluebird Bio to Be Taken Private by Carlyle and SK Capital Amid Cash Crunch
(Reuters) - Gene therapy maker Bluebird bio said on Friday it would be taken private by Carlyle and SK Capital Partners, ...